A randomized double-blind phase II study to evaluate same-day vs nex-day pegfilgrastim with carboplatin and docetaxel in patients with NSCLC

Chandra Belani, S. Ramalingam, A. Al-Janadi, E. Eskander, H. Ghazal, L. Schwartzberg, M. Elliott, S. Shahin, L. Dreiling

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'A randomized double-blind phase II study to evaluate same-day vs nex-day pegfilgrastim with carboplatin and docetaxel in patients with NSCLC'. Together they form a unique fingerprint.